Ryan Halsted
Stock Analyst at RBC Capital
(2.57)
# 2,890
Out of 4,534 analysts
82
Total ratings
58.2%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintained: Buy | $215 | $219.70 | -2.14% | 4 | Jul 8, 2026 | |
| HCSG Healthcare Services Group | Maintained: Hold | $24 | $24.95 | -3.81% | 4 | Jul 8, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $185 | $166.18 | +11.33% | 4 | Jul 8, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | $221 | $203.90 | +8.39% | 5 | Jul 8, 2026 | |
| HQY HealthEquity | Maintained: Buy | $108 | $98.88 | +9.22% | 3 | Jul 8, 2026 | |
| EVH Evolent Health | Maintained: Hold | $3 | $5.93 | -49.41% | 5 | Jul 8, 2026 | |
| MEDP Medpace Holdings | Maintained: Buy | $484 | $527.93 | -8.32% | 5 | Jul 8, 2026 | |
| SHC Sotera Health Company | Maintained: Buy | $24 | $17.42 | +37.77% | 9 | Jul 8, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $31 | $26.26 | +18.05% | 7 | Jul 8, 2026 | |
| DOCS Doximity | Maintained: Buy | $28 | $21.73 | +28.85% | 9 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $22.09 | +99.19% | 7 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $38.88 | +36.32% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $10.68 | +77.90% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $14.93 | n/a | 4 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $40.55 | n/a | 1 | Oct 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $78.00 | n/a | 1 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $172.04 | n/a | 3 | May 12, 2016 |
Charles River Laboratories International
Jul 8, 2026
Maintained: Buy
Price Target: $215
Current: $219.70
Upside: -2.14%
Healthcare Services Group
Jul 8, 2026
Maintained: Hold
Price Target: $24
Current: $24.95
Upside: -3.81%
ICON Public Limited Company
Jul 8, 2026
Maintained: Buy
Price Target: $185
Current: $166.18
Upside: +11.33%
IQVIA Holdings
Jul 8, 2026
Maintained: Buy
Price Target: $221
Current: $203.90
Upside: +8.39%
HealthEquity
Jul 8, 2026
Maintained: Buy
Price Target: $108
Current: $98.88
Upside: +9.22%
Evolent Health
Jul 8, 2026
Maintained: Hold
Price Target: $3
Current: $5.93
Upside: -49.41%
Medpace Holdings
Jul 8, 2026
Maintained: Buy
Price Target: $484
Current: $527.93
Upside: -8.32%
Sotera Health Company
Jul 8, 2026
Maintained: Buy
Price Target: $24
Current: $17.42
Upside: +37.77%
Privia Health Group
Jul 8, 2026
Maintained: Buy
Price Target: $31
Current: $26.26
Upside: +18.05%
Doximity
Jul 8, 2026
Maintained: Buy
Price Target: $28
Current: $21.73
Upside: +28.85%
Jul 8, 2026
Maintained: Buy
Price Target: $44
Current: $22.09
Upside: +99.19%
Jul 8, 2026
Maintained: Buy
Price Target: $53
Current: $38.88
Upside: +36.32%
May 27, 2026
Maintained: Buy
Price Target: $19
Current: $10.68
Upside: +77.90%
Jan 12, 2017
Upgraded: Buy
Price Target: n/a
Current: $14.93
Upside: n/a
Oct 6, 2016
Reiterated: Hold
Price Target: n/a
Current: $40.55
Upside: n/a
Sep 9, 2016
Reiterated: Hold
Price Target: n/a
Current: $78.00
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $22
Current: $172.04
Upside: n/a